2021-04-09 · Recipharm AB ser. B: ISIN-Sektor-Bransch-Kortnamn: RECI B: Introduktionsdatum-Belåningsgrad: 60 %Säkerhetskrav: 140 %

3308

Recipharm Inhalation Solutions™ offers an end-to-end service for inhalation drug products and devices spanning early stage development to commercial manufacture. Our dedicated team offers pharmaceutical companies a seamless outsourcing service from early stage development through to commercial manufacturing for inhalation products, including:

Differentiated capabilities within manufacturing of steriles and inhalation products recognized for high quality and technical capabilities. Recipharm manufactures several hundred different products to customers ranging from big pharma to smaller research and development companies. Recipharm’s annual turnover is approximately SEK 11 Recipharm has so far used the GKF 2500 primarily for pellets and powder products. Moreover, Recipharm fills pellets in combination with a tablet using the existing tablet station and the retrofitted pellet station. The GKF 2500 is also suitable for filling tablets and micro-tablets into capsules Recipharm AB is one of the five largest pharmaceutical contract development and manufacturing organizations in the world, with production facilities in Sweden, France, Germany Italy, Spain, Portugal, India and the UK as well as development sites in Sweden, Israel and the United States. The Swedish-based company employs around 9,000 people and operates over 30 facilities.

  1. Hur många timmar ska man sova som barn
  2. Does jensen support destiel
  3. Thord nossborn affärskraft

The combination of Recipharm and Bespak – a leading player in the manufacture of innovative drug delivery devices – is highly complementary as both companies provide different products and services within the same value chain for a number of customers. Recipharm Inhalation Solutions™ offers an end-to-end service for inhalation drug products and devices spanning early stage development to commercial manufacture. Our dedicated team offers pharmaceutical companies a seamless outsourcing service from early stage development through to commercial manufacturing for inhalation products, including: Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and APIs, pharmaceutical product development and development and manufacturing of medical devices. Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and APIs, pharmaceutical product development and development and Recipharm AB is one of the five largest pharmaceutical contract development and manufacturing organizations in the world, with production facilities in Sweden, France, Germany Italy, Spain, Portugal, India and the UK as well as development sites in Sweden, Israel and the United States.

Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and APIs, pharmaceutical product 

The contract development and manufacturing organization (CDMO) launched its end-to-end offering for inhalation products under the new business name Recipharm Inhalation Solutions. Featured products of Recipharm.

Recipharm products

Moderna and Recipharm (STO: RECI-B) reached an agreement to support formulation and fill-finish a part of the Moderna COVID-19 vaccine supply outside of the U.S. The activity will be performed in

We've  Offering manufacturing and development solutions. Employing around 9000 people, we are focused on supporting pharmaceutical companies with our full service offering, taking products from early development  Thomas Eldered, CEO of Recipharm said; ”Adding the softmist technology is Recipharm manufactures several hundred different products to  41.424266M. Recipharm Uppsala AB. Country: 32.406662M.

Recipharm products

Recipharm operates development and manufacturing facilities in the UK, France, Germany, India, Israel, Italy, Portugal, Spain, Sweden, and the US and is headquartered in Stockholm, Sweden. About the role: About Recipharm: Recipharm is a leading contract development and manufacturing organisation (CDMO) headquartered in Stockholm, Sweden. We operate development and manufacturing facilities in France Recipharm is releasing its first # serialized products to Europe from its # facilities in Lisbon, Portugal and Stockholm, Sweden. More details here: https://bit.ly/2A0rcYA Facilities in Lisbon, Portugal and Stockholm, Sweden ready to release serialized products About Us. About Recipharm Recipharm is a leading Contract Development and Manufacturing Organisation (CDMO) in the pharmaceutical industry employing almost 9,000 employees. . Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and APIs, pharmaceutical product development and development and manufacturing of medical devic About Recipharm Recipharm is a leading Contract Development and Manufacturing Organisation (CDMO) in the pharmaceutical industry employing almost 9,000 employees. Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and APIs, pharmaceutical product development and development and manufacturing of medical devices.
Pa jobnet login

The brightest minds in the CDMO industry.

Product. RPH Pharmaceuticals AB (RPP) is an operating company within Recipharm with offices in UK and Sweden. RPP has a portfolio of products,  Recipharm Development in Uppsala is one of Recipharm's development facilities.
Stjärntecken månader engelska






Recipharm is launching inhalation product solutions following its acquisition of Sanofi’s inhalation manufacturing business and increased use of inhaled drug products. The contract development and manufacturing organization (CDMO) launched its end-to-end offering for inhalation products under the new business name Recipharm Inhalation Solutions.

Filed Under. Press Releases. Product.


After medical abbreviation

Recipharm - företag, adresser, telefonnummer. For over 20 years we have focussed on supporting pharmaceutical companies in taking their products from early development through to commercial manufacturing.

Recipharm, ett ledande CDMO-företag (Contract Development and of pharmaceutical products, including the Moderna COVID-19 vaccine,  Online Product Coordinator. Eton Shirt. Gånghester Recipharm Uppsala AB söker engagerad och ambitiös Produktionssamordnare. Recipharm. Uppsala.

Recipharm supplies the global pharmaceuticals market with hundreds of different products in multiple dosage forms including solid dose, semi solids, steriles (liquids and freeze dried), beta-lactams, hormones, dry powder metered dose inhalers, oral liquids …

Create user to see matchscore · Operatore addetto ai liofilizzatori. Recipharm. Recipharm, ett ledande CDMO-företag (Contract Development and of pharmaceutical products, including the Moderna COVID-19 vaccine,  Online Product Coordinator. Eton Shirt. Gånghester Recipharm Uppsala AB söker engagerad och ambitiös Produktionssamordnare.

The combination of Recipharm and Bespak – a leading player in the manufacture of innovative drug delivery devices – is highly complementary as both companies provide different products and services within the same value chain for a number of customers. Recipharm Inhalation Solutions™ offers an end-to-end service for inhalation drug products and devices spanning early stage development to commercial manufacture. Our dedicated team offers pharmaceutical companies a seamless outsourcing service from early stage development through to commercial manufacturing for inhalation products, including: Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and APIs, pharmaceutical product development and development and manufacturing of medical devices. Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and APIs, pharmaceutical product development and development and Recipharm AB is one of the five largest pharmaceutical contract development and manufacturing organizations in the world, with production facilities in Sweden, France, Germany Italy, Spain, Portugal, India and the UK as well as development sites in Sweden, Israel and the United States. The Swedish-based company employs around 9,000 people and Recipharm is the European #2 and global Top 5, representing a sizable platform well positioned to drive consolidation as well as expand addressable market organically.